Pharmaceutical Mutual funds are funds which primarily invest in pharmaceutical stocks in India.
Since these mutual funds invest money in a single theme/sector, they are categorized as High Risk equity investments.
| Mutual Fund Scheme | NAV | Month | 3 Month | 6 Month | Year | 2 Year | 3 Year | As on (yy-mm-dd) |
|---|---|---|---|---|---|---|---|---|
| SBI Healthcare Opportunities Fund Direct Growth | 500.8 | 5.22% | 6.29% | -0.13% | 22.88% | 74.40% | 125.50% | 2025-07-04 |
| SBI Healthcare Opportunities Fund Regular Growth | 437.5 | 5.13% | 6.01% | -0.64% | 21.60% | 70.75% | 118.41% | 2025-07-04 |
| UTI Healthcare Fund-Growth Option- Direct | 327.8 | 4.07% | 11.89% | 0.32% | 21.24% | 78.52% | 111.64% | 2025-07-07 |
| UTI Healthcare Fund Regular Plan Growth | 290.8 | 3.98% | 11.60% | -0.19% | 20.03% | 75.02% | 105.38% | 2025-07-07 |
| Nippon India Pharma Fund - Direct Plan - Growth Plan | 581.5 | 2.82% | 11.66% | -0.14% | 15.24% | 66.27% | 102.97% | 2025-07-07 |
| Tata India Pharma & Healthcare Fund Direct Payout of Inc Dist cum Cap Wdrl | 35.7 | 3.91% | 9.86% | -1.82% | 14.48% | 70.41% | 104.42% | 2025-07-07 |
| Tata India Pharma & Healthcare Fund Direct Rnvstmnt of Inc Dist cum Cap Wdrl | 35.7 | 3.91% | 9.86% | -1.82% | 14.48% | 70.41% | 104.42% | 2025-07-07 |
| Tata India Pharma & Healthcare Fund Direct Growth | 35.7 | 3.91% | 9.86% | -1.82% | 14.48% | 70.41% | 104.42% | 2025-07-07 |
| Nippon India Pharma Fund - Growth | 522.3 | 2.74% | 11.39% | -0.59% | 14.20% | 63.31% | 97.58% | 2025-07-07 |
| Tata India Pharma & Healthcare Fund Regular Payout of Inc Dist cum Cap Wdrl | 30.7 | 3.76% | 9.42% | -2.60% | 12.76% | 65.37% | 95.54% | 2025-07-07 |
| Tata India Pharma & Healthcare Fund Regular Rnvstmnt of Inc Dist cum Cap Wdrl | 30.7 | 3.76% | 9.42% | -2.60% | 12.76% | 65.37% | 95.54% | 2025-07-07 |
| Tata India Pharma & Healthcare Fund Regular Growth | 30.7 | 3.76% | 9.42% | -2.60% | 12.76% | 65.37% | 95.54% | 2025-07-07 |